Related Experiment Videos
Structure and function of the type 1 insulin-like growth factor receptor
T E Adams1, V C Epa, T P Garrett
1CSIRO Health Sciences and Nutrition, Parkville, Victoria, Australia. Tim.Adams@hsn.csiro.au
Cellular and Molecular Life Sciences : CMLS
|August 29, 2000
Summary
The type 1 insulin-like growth factor receptor (IGF-1R) drives cell growth and survival. Targeting IGF-1R offers a promising therapeutic strategy for cancers like breast and prostate cancer.
Area of Science:
- Cellular Biology
- Molecular Oncology
- Endocrinology
Background:
- The type 1 insulin-like growth factor receptor (IGF-1R) is a transmembrane tyrosine kinase crucial for cell proliferation and apoptosis.
- IGF-1R signaling is vital for fetal growth and plays a role in postnatal growth alongside growth hormone and IGFs.
- Aberrant IGF-1R expression is linked to malignant transformation and observed in various human tumors.
Purpose of the Study:
- To investigate the role of IGF-1R in cell growth, survival, and cancer development.
- To explore the therapeutic potential of targeting IGF-1R in cancer treatment.
- To highlight the significance of IGF-1R structure elucidation for drug development.
Main Methods:
- Review of existing literature on IGF-1R function and expression.
- Analysis of epidemiological studies linking IGF-1 axis to cancer pathogenesis.
- Discussion of structural biology advancements in IGF-1R research.
Main Results:
- IGF-1R overexpression induces malignant transformation; downregulation reverses it.
- Elevated IGF-1R levels are common in human tumors.
- The IGF-1 axis is implicated in breast and prostate cancer development.
Conclusions:
- IGF-1R is a critical regulator of cell growth and survival, making it a key therapeutic target for cancer.
- Targeting IGF-1R may reverse tumor cell transformation and enhance apoptosis sensitivity.
- Understanding IGF-1R structure facilitates the rational design of small molecule antagonists for clinical application.